Company ProfilePremium

Aeris Environmental Ltd

Company Profile Analysis

Ticker: AEI.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Aeris Environmental Ltd - Company showcase

Year Founded & Workforce

2000

21 Employees

Aeris Environmental Ltd logo

Aeris Environmental Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Aeris Environmental Ltd Overview

Aeris Environmental is a Sydney-based micro-cap with two lines of business. The first is a specialty environmental chemicals business: HVAC&R coil hygiene, corrosion protection coatings, mould remediation and disinfectants. The second is AerisTech, a 60%-owned IoT building-intelligence subsidiary whose patented Syncromesh wireless mesh platform connects lighting, HVAC and sensors to a cloud analytics layer without re-cabling. After a pandemic-era spike in disinfectant sales (FY2020 revenue A$14.6M), revenue has settled around A$3M a year since FY2022. The company now positions itself as an integrated "chemistry plus data" provider for energy efficiency, asset protection and indoor environmental quality. Its growth vectors are the Syncromesh Omni wholesale kit, enterprise deployments of Syncromesh Prime (including an Australian bank), corrosion-protection OEM orders in the Middle East and US, and brewery hygiene in China, including Budweiser APAC. The investment case is constrained by a weak balance sheet. At 30 June 2026 the company had net liabilities of A$9.2M and A$12.3M of related-party borrowings classified as current, and its accounts carry an explicit going-concern material-uncertainty note [AR26].


The company's own description [AR26, Directors' Report – Principal Activities]. Aeris describes three principal activities:

  • research, development and commercialisation of proprietary technologies, and global distribution of HVAC/R hygiene, anti-corrosion and disinfectant products;

  • HVAC/R hygiene and remediation, indoor air quality and corrosion protection services;

  • development and commercialisation of the AerisTech Syncromesh ecosystem, a wireless IoT platform and cloud software for monitoring and managing smart-building asset performance.

The Directors state there was no significant change in the nature of activities in FY2026.

Independent characterisation. Aeris is effectively two businesses sharing one listed balance sheet.

Specialty chemicals: This is the established revenue base. It consists of formulated products made by contract manufacturers in Australia and, from FY2026, partly in China. The products are sold through wholesalers, OEMs, HVAC contractors and directly to enterprises. Its margin profile is typical of a specialty chemicals business: the company states a gross margin of 51–53%. Demand has historically been lumpy. It is driven by weather events (North Queensland mould remediation in FY2025), pandemic hygiene spending (FY2020–21) and single large orders, such as a ~A$308k repeat order from a UAE OEM in the June 2026 quarter [AR26].

AerisTech / Syncromesh: This is an early-commercial building-IoT platform. The hardware is a mesh of wireless nodes and gateways. The software is a cloud dashboard and analytics layer. The business model mixes upfront capital (hardware and installation) with recurring cloud and application revenue. Management describes add-on applications as generating high-margin, recurring, cloud-based revenue once the network is installed [AR26].

Revenue model mix (FY2026) [AR26 Note 5]:

The FY2026 mix shifted sharply from services to products. Services revenue fell 75%, from A$1.21M to A$0.30M, as weather-driven mould remediation in North Queensland normalised. Product sales rose 47% [AR26]. Subscription and licensing revenue is not separately disclosed. Syncromesh recurring cloud revenue is presumably embedded within sales and services, but it is not quantified.

Value-chain position. Aeris is an IP-owning formulator and brand owner, not a commodity chemical producer. It outsources most manufacturing and relies on distribution partners: electrical wholesalers, HVAC wholesalers, a US channel partner (H4 Enterprises), a UK distributor and integrator, and Amazon in the US (per a third-party summary of the July 2026 quarterly [AGG]). Related-party entities supply R&D (Novapharm Research), corporate services and distribution (Regional Corporate Services), and some product (Enviroguard Technologies) [AR26].

Customer types and end-markets. Customers include HVAC&R contractors and OEMs; commercial property owners and facility managers; financial institutions, including a leading Australian bank rolling out Syncromesh Prime; government infrastructure owners; aged care and health (Queensland Health became a direct supplier relationship in 2024 [AGG]); sporting and entertainment venues (Luna Park Melbourne [Q-Jan26]); breweries in China (Budweiser APAC, Beijing Yanjing Brewery); coil manufacturers (a US coil maker after year-end); and residential and flood-remediation customers.

Customer concentration. One customer accounted for about 37% of FY2026 external revenue, up from 6% in FY2025, through the Australian segment [AR26 Note 4]. The customer is not named.

Strategy

Stated strategy themes (paraphrased from AR26):

  1. Focus where technology is differentiated. Concentrate on markets with a credible route to commercial scale: corrosion protection, mould remediation and hygiene in chemicals, with growing focus on China, the Middle East and the US; and building intelligence via Syncromesh.

  2. Two routes to market for AerisTech. Pursue large enterprise deployments directly and through integrators (Prime), and use the electrical wholesale channel for scalable volume (Omni). The wholesale model is meant to grow the pipeline without a matching increase in direct sales and delivery resources.

  3. Chemistry plus data. Position specialty chemicals to work with IoT data so customers can improve efficiency and environmental outcomes, and cross-sell both lines.

  4. Recurring revenue. Use the installed Syncromesh network as a base for high-margin cloud applications, and build repeat order books in corrosion protection.

  5. Financial discipline. Maintain gross margin, control expenditure and working capital, and expand the capital base "at the appropriate time".

ESG commitments. No formal emissions targets are disclosed. The product proposition relies on customers' regulatory drivers: NABERS, Scope 2 reporting and IFRS S1/S2 (AASB S2) climate disclosure in Australia; and China's chemical-safety and food-safety rules.

Cost programmes. No formal programme with numeric targets has been disclosed.

Medium-term financial targets. None published. The Likely Developments section of AR26 withholds forward guidance, citing unreasonable prejudice. The going-concern note refers to an internal sales budget expecting "material growth" from new product introductions. The CEO's incentive hurdle (EBITDA of at least 10% of sales; VWAP of at least A$0.50) gives an implicit aspiration, not guidance.

Products & Services

Pricing is not publicly disclosed for any product unless stated. Launch years are given only where documented.

5A. AerisTech — Building Intelligence

ProductDescription & capabilitiesTarget customerLaunch / statusPricing model
Syncromesh (core platform)Proprietary, patented wireless mesh of nodes and gateways that links lighting, HVAC and other building systems to a cloud platform without re-cabling. Automates lighting and climate, tracks energy by zone, and monitors occupancy and environmental conditions in real time. Interoperates with existing building management systems and third-party IoT/power-monitoring OEM devices [AR26; AR25]Commercial and industrial buildings, new build and retrofitTechnology originated with Cognian; brought into AerisTech in Sep 2024Hardware and installation (capital) plus recurring cloud/application revenue [AR26]
Syncromesh PrimeProject-engineered version for larger or complex sites, where an integrator designs the network to specification. Deployed at commercial, aged care, sporting facilities, a complex lighting-control site (Luna Park Melbourne) and a leading Australian bank [AR26; Q-Jan26]Enterprises, government infrastructure, integratorsCommercial since FY2025; scaling in FY2026Project pricing; not disclosed
Syncromesh OmniStandard pre-configured kit that an electrician can select, order and install without bespoke design. Aimed at smaller and retrofit commercial premises through electrical wholesale channels [AR26]Electricians and electrical wholesalers; SME commercial premisesCommercial launch targeted for Q1 FY2027 (Jul–Sep 2026) [Q-Apr26]; AR26 says it is now listed with major wholesalers and generating growing ordersWholesale kit pricing; not disclosed
Thermal occupancy sensingCamera-free people counting and dwell-time measurement, described as privacy-assured and free of the issues of AI camera installs [AR26]Banks, retail, officesPart of Prime deploymentsBundled
Cloud dashboard / analyticsBespoke cloud dashboard providing actionable energy and occupancy data; supports NABERS, Scope 2 and IFRS S1/S2 reporting needs [AR26; Q-Apr26]Facility managers and ESG reporting teamsLiveRecurring; not disclosed

5B. Specialty Chemicals — Corrosion Protection

ProductDescriptionTarget customerNotes
Corrosion protection coatings for HVAC coils (Aeris Coil Protect range)Thin specialty coatings for air-conditioning heat exchangers that do not impair heat-exchange performance. Independently tested to the ASTM B117 salt-spray standard; still passing after more than five years of continuous exposure [AR26]HVAC&R contractors, OEMs, owners of coastal, marine, offshore, humid industrial and food-plant assetsPrincipal FY2026 growth area; repeat orders from a UAE OEM; customers in Saudi Arabia, Qatar and Australia; first US coil-manufacturer order after year-end

5C. Specialty Chemicals — HVAC&R Hygiene, Mould & Environmental Hygiene

ProductDescriptionTarget customerNotes
AerisGuard multi-enzyme coil/HVAC hygiene rangePatented multi-enzyme antimicrobial cleaners that remove contaminants and protect against recontamination, with protection claims of up to 12 months [AGG – Small Caps]HVAC contractors, facility managersLong-standing core range
Indoor Coil Treatment (aerosol 200g, AG-CT-A; 5L, AG-CT-5)Ready-to-use coil treatment; validated coil efficiency improvement; 12-month protection claim [product sheet, aeris.com.au]HVAC servicingCurrent
Aeris Guard Bioactive Filter TreatmentBiodegradable active biocide for filters, claimed to kill 99.99% of bacteria and enveloped viruses [AGG – trade press]HVAC filtersPandemic-era addition
Mould prevention / Mould Stop PaintMould-control coating and remediation chemistry; Mould Stop Paint referenced in the March 2026 quarter [Q-Apr26]Residential, aged care, flood/mould remediationCurrent
Enzyme-based cleaning chemistry and anti-biofilm formulations (China)Formulations against biofilm and microbial fouling that protect heat-exchange assets in breweries [AR26]Brewers (Budweiser APAC, Yanjing)Locally manufactured in China from FY2026
Seal repair and hygiene automation solutionsPart of the Budweiser APAC opportunity set [AR26]BrewersEarly stage

5D. Specialty Chemicals — Surface Disinfection

ProductDescriptionNotes
Aeris ActiveDual-active biocide hospital-grade disinfectant listed on the ARTG. Residual claims of up to seven days against COVID-19 and up to 30 days (200 touches) antibacterial; on Singapore NEA's interim COVID-19 list [AGG – trade press, 2020]Main driver of FY2020 revenue
Aeris Defence (750mL trigger AG-AD-750; 5L AG-AD-5)TGA-approved, Australian-made broad-spectrum disinfectant cleaner. Kills COVID-19, influenza and bacteria in a single step, with 24-hour ongoing disinfection after a single application [product sheet; Australian Made]Current range
Hard-surface disinfecting paperBiodegradable, renewably sourced disinfecting wipes/paper [AGG – trade press]Pandemic-era line

5E. Services

ServiceDescriptionFY2026 revenue
HVAC/R hygiene and remediation; IEQ / indoor air quality services; flood and mould remediation; corrosion protection servicesOver-time service contracts, concentrated in North Queensland remediation in FY2025A$297,895 (FY2025: A$1,212,441) [AR26]

Financial Narrative

Income statement

Notes:

  • TipRanks shows FY2024 gross profit as -A$0.18M, which is inconsistent with the company's stated margins and probably reflects an inventory write-down classification. It is excluded as unverifiable.

  • The company states gross margin as 51% (FY2025) and 53% (FY2026) [AR26]. Gross profit computed from statutory sales less cost of sales gives 47.5% and 51.2% respectively. The difference likely reflects management's definition, for example a quarterly or product-only basis.

Margins (%) — derived

Revenue CAGR: FY2022–FY2026 ≈ +3.5% a year (derived). FY2021–FY2026 ≈ -15.5% a year (from A$7.13M). FY2020–FY2026 ≈ -22.9% a year (from A$14.63M).

Half-year and quarterly revenue: notes and sources

Sources: AR26 for Q1 and Q4; Q2 derived from HY26 H1 revenue of A$1,077,773; [Q-Jan26], [Q-Apr26], [Q-Jul26].

Balance sheet

Notes:

  • FY2023 figures (cash, total assets, current liabilities of A$1.67M) and FY2024 cash and long-term debt are from InvestSMART/Morningstar [AGG].

  • FY2024 equity is the opening balance at 1 July 2024 from the AR26 statement of changes in equity.

  • Inventory is carried net of a A$2.48M impairment provision against gross inventory of A$3.25M [AR26 Note 10]. This is a large legacy write-down, most likely of pandemic-era disinfectant stock.

Borrowings detail [AR26]:

  • Loans from Directors and a shareholder total A$11,152,904 at a fixed 10%. They include capitalised interest; AR26 reports facilities of A$10.17M plus A$0.98M capitalised interest.

  • Loans from JV partner Cognian total A$1,191,000 and are non-interest-bearing.

  • Director loan balances at year-end: Maurie Stang A$4,544,383; Steven Kritzler A$2,231,845. The balance is attributable to substantial shareholder Bernard Stang (by inference from the AGM resolution).

  • All borrowings were reclassified from non-current to current under their repayment terms.

Cash flow

FY2022–FY2024 operating cash flow is from Stoxray/InvestSMART [AGG].

Ratios — derived

ROE, ROIC and debt/equity are not meaningful (n/m) because equity is negative and EBITDA is negative.

Commentary

Revenue. The revenue history has three phases. First, a pandemic boom: FY2020 revenue of A$14.6M and a profit of about A$2.0M, driven by the ARTG-listed Aeris Active disinfectant. Second, a sharp normalisation: A$7.1M in FY2021, then A$2.7M in FY2022 and A$1.9M in FY2023, with large losses and inventory write-downs. Third, a stabilisation at A$3.0–3.3M a year in FY2024–FY2026. FY2026 revenue fell 5.5% to A$3.08M. This masks a sharp change in mix and timing. The December 2025 quarter was very weak (about A$0.38M), while the June 2026 quarter was the strongest in at least two years (A$1.27M), driven by corrosion orders from the UAE OEM and Budweiser APAC. H2 FY2026 revenue of A$2.0M was up 13% on H2 FY2025 (derived). This is the most constructive data point in the filings.

Margins. Gross margin improved to a company-stated 53% from 51%, helped by the shift to product sales and the planned move of some manufacturing to China. The operating cost base of A$7.2M is about 2.3 times revenue, so breakeven at current gross margins would require revenue of roughly A$13–14M (derived). Administration costs rose 18% (corporate overheads up 25%), and finance costs rose 166% as related-party debt compounded at 10%.

Balance sheet. The balance sheet has deteriorated sharply. Shareholders' equity fell from roughly nil at 1 July 2024 to -A$9.2M at 30 June 2026. Accumulated losses reached A$73.1M against issued capital of A$62.5M. Borrowings have funded operations instead of equity since FY2025; there was no meaningful equity issue in either year. The current ratio collapsed to 0.36 because the A$12.3M of loans became current. The Directors intend to negotiate an extension, and say that if the loans were extended, current assets would exceed current liabilities by A$3.07M [AR26].

Working capital. The cash conversion cycle widened as trade receivables doubled. A A$324,630 fully-provided receivable was written off. Receivables older than 90 days were A$341k at year-end with no provision, which is worth monitoring [AR26 Note 9].

Going concern. AR26 Note 1 discloses a material uncertainty about the group's ability to continue as a going concern. It states the group remains dependent on capital raisings and that funding options, including a 2026 capital raise, have been investigated.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Entity / Unit Details

Entity / unitOwnershipFunction

Aeris Environmental Ltd

Listed parent

Head entity of the Australian tax-consolidated group; specialty chemicals

AerisTech Pty Ltd

60% Aeris / 40% Cognian Technologies Limited

Syncromesh building-intelligence platform (Prime and Omni)

US subsidiary

Wholly owned (implied by US tax losses of A$5.39M)

Legacy US operations; corrosion and coil sales

UK subsidiary

Wholly owned (UK tax losses)

UK distribution and Syncromesh

China subsidiary

Wholly owned (China tax losses)

Aeris China team; local manufacturing capability

Revenue by Segment

Segment (AUD Mn)FY2025FY2026

Australia – revenue from external customers

2.9492.750

International – revenue from external customers

0.0820.220

Total sales revenue (contracts with customers)

3.0302.970

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment — Australia – segment sales

Segment (AUD Mn)FY2025FY2026

Australia – segment sales

3.1333.075

International – segment sales

0.0820.220

Intersegment eliminations

-0.184-0.325

Segment pre-tax profit/(loss) (AUD Mn)

Segment pre-tax profit/(loss) (AUD Mn)FY2025FY2026

Australia

-4.339-5.592

International

-0.562-0.239

Eliminations

0.3170.245

Consolidated loss before tax

-4.584-5.587

Segment Margins & Growth (%) and Revenue by Segment (%)

MetricFY2025FY2026

Australia external revenue YoY growth (%)

—-6.7

International external revenue YoY growth (%)

—168.7

Australia share of external sales (%)

97.392.6

International share of external sales (%)

2.77.4

Australia PBT / segment sales (%)

-138.5-181.9

International PBT / segment sales (%)

-687.5-108.6

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

2.6781.9303.0463.2613.080

Revenue from contracts with customers (AUD Mn)

———3.0302.970

Gross profit on sales (AUD Mn, derived)

1.210.947—1.4391.521

Operating income / EBIT (AUD Mn, derived for FY25–26)

-7.33-3.98-2.98-4.309-4.806

EBITDA (AUD Mn, derived for FY25–26)

-7.31-3.86-2.98-4.227-4.729

Finance costs (AUD Mn)

———0.2990.796

Pre-tax income (AUD Mn)

-7.42-4.03-3.10-4.584-5.587

Income tax benefit, mainly R&D offset (AUD Mn)

———0.4620.419

Net income, total (AUD Mn)

-7.13-3.65-2.97-4.122-5.167

Net income attributable to owners (AUD Mn)

-7.130-3.654-2.973-3.869-4.764

EPS basic (A$ cents)

-2.92-1.49-1.21-1.57-1.93

EPS diluted (A$ cents)

-2.92-1.49-1.21-1.57-1.93

Dividends per share (A$ cents)

00000

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Gross margin on sales (%)

45.249.1—47.551.2

Gross margin, company-stated (%)

———5153

Operating margin (%)

-273.7-206.2-97.8-132.2-156.0

EBITDA margin (%)

-272.9-200.0-97.8-129.6-153.5

Net margin, total loss (%)

-266.2-189.1-97.5-126.4-167.7

Expense line (AUD Mn)

Expense line (AUD Mn)FY2025FY2026

Cost of sales

1.5921.449

Employee benefits

1.8251.778

Administration (total)

2.5122.966

of which compliance cost

0.9431.060

of which corporate and overheads

1.3831.726

Distribution

0.5720.537

Sales, marketing and travel

0.3040.410

R&D and patent expense

0.4990.358

Occupancy

0.1640.208

Finance costs

0.2990.796

Depreciation and amortisation

0.0810.077

Impairment (net)

-0.0050.088

Total expenses

7.8448.667

Period revenue (AUD Mn)

Period revenue (AUD Mn)FY2023FY2024FY2025FY2026

H1 revenue

1.0811.6111.4961.078

H2 revenue (derived)

0.8491.4351.7652.003

FY2026 quarterly revenue (AUD Mn)

Q1 Sep-25

Q2 Dec-25

Q3 Mar-26

Q4 Jun-26

Revenue (AUD Mn)

0.6990.3790.7291.274

Cash receipts (AUD Mn)

—0.6910.5880.775

Balance Sheet and Per-Share Data

MetricFY2023FY2024FY2025FY2026

Total assets (AUD Mn)

4.73—3.3365.210

Cash and equivalents (AUD Mn)

2.600.9900.8832.048

Trade receivables, net (AUD Mn)

——0.5161.076

R&D tax offset receivable (AUD Mn)

——0.6260.985

Inventories, net (AUD Mn)

——0.7700.767

Borrowings – current (AUD Mn)

——012.344

Borrowings – non-current (AUD Mn)

0.050.865.3330

Lease liabilities (AUD Mn)

——0.1250.073

Net debt incl. leases (AUD Mn, derived)

——4.57610.369

Total equity (AUD Mn)

—-0.028-4.116-9.218

Goodwill and intangibles (AUD Mn)

——0.0040.003

Working capital (AUD Mn, derived)

2.80—1.122-9.274

NTA per share (A$ cents)

——-1.72-3.77

Cash Flow

MetricFY2022FY2023FY2024FY2025FY2026

Receipts from customers (AUD Mn)

———3.1242.646

Operating cash flow (AUD Mn)

-6.107-2.583-1.985-4.279-5.029

Capex (AUD Mn)

———-0.010-0.011

Free cash flow (AUD Mn, derived)

———-4.290-5.040

Related-party loans received (AUD Mn)

———4.2396.283

Equity issued (AUD Mn)

———00.006

Dividends paid (AUD Mn)

00000

Buybacks (AUD Mn)

00000

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2025FY2026

ROE (%)

n/m

n/m

ROA (%, loss / average assets)

—-121.0

ROIC (%)

n/m

n/m

Current ratio (x)

1.550.36

Debt / equity (x)

n/m

n/m

Net debt / EBITDA (x)

n/m

n/m

Interest coverage, EBIT / finance costs (x)

-14.4-6.0

Asset turnover (x, revenue / average assets)

—0.72

Receivable days, trade only

62132

Inventory days

177193

Payable days

215211

Cash conversion cycle (days)

24114

Region revenue (AUD Mn)

Region revenue (AUD Mn)FY2025FY2026

Australia (AUD Mn)

2.9492.750

International (AUD Mn)

0.0820.220

Region YoY growth (%)

Region YoY growth (%)FY2026

Australia (%)

-6.7

International (%)

168.7

Revenue by Region

Category (AUD Mn)FY2025FY2026

Australia – point in time

1.7362.453

Australia – over time (services)

1.2120.298

International – point in time

0.0820.220

Margin Analysis (%) — Share price change, financial year

MetricFY2022FY2023FY2024FY2025FY2026

Share price change, financial year (%)

-68.00-47.92148.00-40.00-11.00

Valuation Multiples

MultipleAerisComment

Market cap

~A$7.4M

~247M shares

Enterprise value

~A$17.8M

Market cap + A$12.42M debt and leases − A$2.05M cash

EV / Sales (FY2026)

~5.8x

—

EV / EBITDA

n/m

Negative EBITDA

P/E

n/m

Loss-making

P/B

n/m

Negative book value

Debt Facilities

FacilityAmount (AUD)RateMaturity

Director and shareholder loans

11,152,904

10% fixed

Classified current (due within 12 months); extension intended

Cognian (JV partner) loans

1,191,000

Nil

Classified current

Lease liabilities

73,056

Market rate

34.6k current, 38.4k non-current

Analyst Conclusions

Management guidance. No quantitative guidance has been given. AR26 sets out FY2027 priorities:

  • grow Syncromesh Prime installations and enterprise opportunities into larger, repeatable revenue streams;

  • scale Syncromesh Omni orders through electrical wholesalers;

  • increase repeat corrosion-protection orders;

  • convert the China portfolio into stable recurring revenue;

  • keep gross margin attractive while controlling expenditure.

The going-concern note refers to an internal budget expecting material sales growth from new products.

Consensus. No sell-side coverage exists.

Bull case:

  1. Revenue inflection is visible in the quarterly data. Quarterly revenue rose from A$0.38M (Dec-25) to A$1.27M (Jun-26), and H2 FY2026 revenue was up about 13% on the prior year. This came from repeat OEM corrosion orders and Budweiser expansion, which are more durable than weather-driven services.

  2. Omni wholesale gives operating leverage. With gross margin above 50% and largely fixed opex of about A$7M, each additional A$1M of revenue drops roughly A$0.5M toward breakeven. A wholesale channel can scale without proportional cost.

  3. Strategic optionality. Blue-chip validation (an Australian bank, the AT&T-linked deployment, Budweiser APAC, Yanjing, a UK integrator) makes Syncromesh or the chemicals IP an attractive tuck-in for a larger player. A$13.35M of unrecognised tax assets add value for an acquirer.

Bear case:

  1. The balance sheet is the binding constraint. Net liabilities are A$9.2M, A$12.3M of 10% debt is current, and the going-concern uncertainty is explicit. Any equity raise at about A$0.03 against a A$7M market cap would be heavily dilutive, or the company would sink further into insider debt.

  2. There is no track record of sustained growth. Revenue has stayed at A$1.9–3.3M for five years, and FY2026 revenue fell 5.5% despite the "largest" investment year. The cost base is about 2.3 times revenue.

  3. Governance and concentration risk. The controlling holders are also lenders and related-party suppliers, and one customer generates 37% of revenue. Outside shareholders' interests could diverge from those of the lender-shareholders in any restructuring.

Key catalysts and monitorables (next 12 months):

  • Outcome of the loan-extension negotiations, which would shift borrowings back to non-current.

  • Any capital raising: its size, price and participants.

  • September 2026 quarterly 4C (due end of October 2026): Omni orders, cash receipts and run-rate.

  • Number of Omni wholesale listings and orders; conversion of the UK and US pipelines.

  • Further UAE OEM orders (expected in H1 FY2027) and volume from the US coil manufacturer.

  • Budweiser and Yanjing order volumes; margins from China manufacturing.

  • 2026 AGM resolutions and any exercise of the option over Cognian's 40% of AerisTech.

  • H1 FY2027 results (due February 2027), including the auditor's going-concern wording.

Analyst verdict. Aeris Environmental is a 26-year-old micro-cap trying to rebuild after a pandemic boom that briefly took revenue to A$14.6M and then unwound. The company has made a credible strategic choice. It has coupled its specialty HVAC chemicals franchise, where it holds genuine technical credentials (ASTM B117 corrosion data at more than five years, ARTG disinfectant claims, two-year Budweiser accreditation), with an IoT building-intelligence platform whose camera-free occupancy sensing and wireless retrofit design address real regulatory and energy-cost drivers. Commercial proof points are accumulating, and the June 2026 quarter's A$1.27M of revenue suggests the order book is converting.

The financial position, however, overrides the operating narrative. At 30 June 2026, Aeris had A$2.05M of cash against A$14.4M of liabilities. Nearly all of those liabilities are current related-party loans compounding at 10%. Equity is -A$9.2M and annual operating cash burn is about A$5M. The audited accounts carry a going-concern material uncertainty, and the company's survival currently depends on the continued goodwill of its Chairman, a fellow founding director and a related substantial shareholder. The market's roughly A$7M valuation reflects that dependence. The most likely path forward is a recapitalisation: a debt-to-equity conversion, a rights issue, or both. Existing minority holders face significant dilution in that scenario, even if the business itself progresses.

For an institutional reader, AEI is uninvestable on liquidity and governance grounds and is best treated as a watch-list special situation. The thesis would become actionable only on three observable conditions:

  1. a recapitalisation that removes the near-term refinancing overhang on transparent terms;

  2. two or more consecutive quarters of revenue above A$1M with cash receipts tracking revenue;

  3. quantified Syncromesh Omni wholesale volumes demonstrating channel pull-through.

Until then, the risk-reward favours caution despite the encouraging commercial momentum.


Sources consulted

  • Aeris Environmental Ltd, FY2026 Annual Financial Report and Appendix 4E (28 Aug 2026), via ASX / Webull bulletin mirror

  • Aeris Environmental Ltd, FY2025 Annual Report (29 Aug 2025), ASX

  • Half Year Reports for H1 FY2024 (23 Feb 2024), H1 FY2025 (27 Feb 2025) and H1 FY2026 (27 Feb 2026), ASX

  • Quarterly Activities Reports and Appendix 4C for Jan 2026, Apr 2026 and Jul 2026, ASX / Webull / InvestorPA mirrors

  • Reuters brief, AerisTech JV with Cognian (20 Sep 2024)

  • Aggregators: TipRanks, InvestSMART/Morningstar, Market Index, Simply Wall St, Stoxray, FNArena, Kalkine Media, Morningstar AU, Eulerpool

  • Trade press: Small Caps, HVAC&R News, Appliance Retailer, LabOnline, Australian Made licensee pages

  • Aeris product sheets on aeris.com.au

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Executive Leadership Team

NameTitleAppointedBackgroundFY2026 total remuneration (AUD)

Andrew Just

Chief Executive Officer

28 Mar 2022

B.Ec, H.Ec, MBA, GAICD. Former Regional Director Asia Pacific of Radiometer (a Danaher company); about 30 years with GE Healthcare, Danaher, Stryker and Cochlear. NED of Singular Health Group (ASX:SHG) since Mar 2021 and Archer Materials (ASX:AXE) since Dec 2025

335,700 (salary 305,700 + super 30,000)

Robert J. Waring

Company Secretary

25 Jul 2002

B.Ec, CA, FCIS, FFin, FAICD; 50+ years in finance and corporate roles; director of Oakhill Hamilton Pty Ltd; also Company Secretary of Vectus Biosystems (ASX:VBS)

Not disclosed separately (not KMP)

Board of Directors

NameRoleSinceIndependence (analyst view)Background

Maurie Stang

Non-Executive Chairman

24 Jul 2002

Not independent: major shareholder, lender and related-party counterparty

40+ years building healthcare and biotech companies; Executive Chairman of Lumitron Technologies Inc. since 2016; Non-Executive Deputy Chairman of Vectus Biosystems (ASX:VBS) since Dec 2005

Steven Kritzler

Non-Executive Director

24 Jul 2002

Not independent: major shareholder, lender, related-party counterparty

M.Sc in polymer chemistry (UNSW); holds international patents; Technical Director of Novapharm Research (Australia); 40+ years of commercial R&D

Dr Abbie Widin

Non-Executive Director

2 Mar 2021

Independent

PhD, GAICD; senior roles at Procter & Gamble (Europe/Australia) and Kellogg (APAC); founded an Australian robotics/AI company for the built environment; NED of the Agricultural Business Research Institute

Dr Jenny Harry

Non-Executive Director

21 Apr 2021

Independent

PhD, GAICD, Harvard Business School GMP; co-founder of Proteome Systems; NED of Neuren Pharmaceuticals (ASX:NEU) since Jul 2018 and Genetic Signatures (ASX:GSS) since Oct 2024; NED of Lumitron Technologies Inc.

Directors' Remuneration

NameFees/salary FY2026 (AUD)Super (AUD)Options (AUD)Total FY2026 (AUD)Total FY2025 (AUD)

Maurie Stang

81,0818,91924,128114,12890,000

Steven Kritzler

53,5716,42924,12884,12860,000

Abbie Widin

57,1436,857064,00064,000

Jenny Harry

64,2867,714072,00072,000

Andrew Just

305,70030,0000335,700342,293

Total KMP

561,78159,91948,256669,956628,293

Major Shareholders

HolderShares% of ~247M (derived)Notes

Maurie Stang (incl. related entities)

32,088,487

~13.0

Plus 1,000,000 options; lender of A$4.54M

Steven Kritzler (incl. related entities)

21,919,452

~8.9

Plus 1,000,000 options; lender of A$2.23M

Bernard Stang

—

Substantial holder

Change-in-substantial-holding notice lodged 27 Feb 2026; lender; 1,000,000 options

Andrew Just (CEO)

250,000

~0.1

—

“—” = not publicly disclosed.

Competitive Landscape

Key Competitors

CompetitorSegment overlapApprox. FY2024 revenueRelative positioning vs Aeris

Siemens Smart Infrastructure (incl. Enlighted IoT)

Building intelligence, lighting/occupancy IoT

~€21bn (segment)

Dominant BMS and IoT incumbent; Aeris differentiates on wireless retrofit and low cost

Johnson Controls (OpenBlue)

Building automation

~US$23bn

Enterprise BMS leader

Honeywell Building Automation

BMS and sensors

~US$6–7bn (segment)

Incumbent with strong channels

Schneider Electric (EcoStruxure Building)

BMS and energy management; electrical wholesale

~€38bn (group)

Strong in the wholesale channel Omni targets

Signify (Interact)

Connected lighting control

~€6bn

Direct overlap in lighting-led IoT

Ecolab

Industrial hygiene, food and beverage (brewery) sanitation

~US$15.7bn

Global leader in brewery hygiene; main rival for Budweiser-type accounts

Diversey (Solenis)

Institutional and food-and-beverage hygiene

Not publicly disclosed post-acquisition

Hygiene incumbent

Blygold

HVAC coil anti-corrosion coatings

Private; not disclosed

Direct competitor in coil protection

Heresite Protective Coatings

HVAC coil coatings for OEMs

Private; not disclosed

Direct OEM coil-coating competitor

Bluefin (US coil coatings) / Electrofin

Coil coatings

Private; not disclosed

Direct competitor in the US

Nu-Calgon / RectorSeal

HVAC coil cleaners, enzyme cleaners

Private / part of CSW Industrials

Competes on AerisGuard-type products

Envirosuite (ASX:EVS)

Environmental monitoring software (ASX peer)

~A$60–70M

Listed ASX environmental-tech comparator

Peer Comparison FY2026

MetricAeris (FY2026)Ecolab (FY2024)Johnson Controls (FY2024)Siemens SI (FY2024)

Revenue

A$3.1M

~US$15.7bn

~US$23bn

~€21bn

Revenue growth

-5.5%

Low single digit

Low single digit

High single digit

Gross margin

51–53%

~43%

~35%

—

Operating margin

-156%

~15–17%

~10–12%

~15–17%

R&D intensity

~12% (expense line)

~1–2%

~2–3%

—

Company Snapshot

$2M

Revenue

21

Employees

2000

Founded

Rosebery, Australia

Headquarters

SWOT Analysis

Strengths

  • Improving gross margin. Company-stated gross margin rose to 53% in FY2026 from 51% despite inflation [AR26].
  • Commercially validated IoT platform with blue-chip references. These include a leading Australian bank scaling Syncromesh Prime, government infrastructure customers and Luna Park Melbourne [AR26; Q-Jan26].
  • Hard-won accreditation in China. A two-year supplier accreditation with Budweiser APAC now spans six breweries; an initial order was won from Yanjing (41 breweries) [AR26].
  • Recurring corrosion orders. A UAE OEM placed a ~A$308k repeat order in Q4 FY2026, and a first US coil-maker order followed after year-end [AR26].
  • Committed insider support. Directors and their associates have lent A$11.15M and hold about 22% of shares [AR26].
  • Large unrecognised tax assets. A$43.9M of Australian tax losses and A$5.4M of US tax losses are carried forward, a deferred tax asset of A$13.35M not recognised [AR26 Note 7].
  • Regulatory tailwinds explicitly aligned to products. NABERS, Scope 2 and IFRS S1/S2 support Syncromesh; China's chemical-safety and food-safety rules support the hygiene range [AR26].

Weaknesses

  • Negative equity of A$9.22M and NTA of -3.77 cents per share at 30 June 2026 [AR26].
  • Going-concern material uncertainty disclosed in Note 1 of AR26.
  • Cash burn exceeds revenue. Operating cash outflow was A$5.03M against receipts of A$2.65M in FY2026 [AR26].
  • Customer concentration. One client was 37% of FY2026 revenue, up from 6% [AR26 Note 4].
  • Rising finance costs. Finance costs grew to A$0.80M (+166%) on 10% related-party loans [AR26].
  • Heavy related-party dependence. Related parties are involved in services, R&D, distribution, product supply and funding: roughly A$0.88M of related-party expenses in FY2026 plus all borrowings [AR26].
  • Legacy inventory problem. A A$2.48M impairment provision sits against A$3.25M of gross inventory (76%) [AR26 Note 10].

Opportunities

  • Syncromesh Omni via electrical wholesalers. This gives scalable distribution without direct sales cost [AR26].
  • US expansion. Opportunities include H4 Enterprises' US Federal pipeline, the AT&T-linked convenience-chain deployment and the coil-manufacturer channel [AR26].
  • UK expansion. A leading integrator has adopted Syncromesh as its preferred platform [AR26].
  • China brewing. Yanjing's network of 41 breweries is mostly untapped, Budweiser is broadening into four product categories, and local manufacturing should lift margins [AR26].
  • Recurring cloud revenue from additional applications on the installed network base [AR26].
  • Option to buy out Cognian's 40%, which would consolidate Syncromesh economics [HY25].

Threats

  • Funding risk. All A$12.34M of borrowings are current. If extensions fail, a highly dilutive equity raise could follow at a share price of about A$0.03 [AR26].
  • Incumbent response. Siemens, Schneider and Signify already sell wireless lighting and IoT through the same wholesale channels.
  • Weather dependence. FY2026 services revenue fell 75% as North Queensland demand normalised [AR26].
  • Share-price weakness limits equity funding. The share price fell about 46% in calendar 2026 to date and is down roughly 95% from early-2020 levels [AGG].
  • Commodity hygiene competition from Ecolab and Diversey in China and APAC.
  • Key-person and governance concentration. The Chairman is lender, major holder and related-party supplier, and committees have only two members [AR26].

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
Apr 2025Planned commercial launch of the AerisTech solution (per HY25)Start of Syncromesh commercialisation under Aeris
10 Jun 2025Director Kritzler off-market purchase of 2.5M shares at A$0.03 [AGG – Market Index]Insider buying (see the Section 9 discrepancy)
23 Jun 2025Stang and Kritzler each reported buying 8.17M shares at A$0.037 [AGG]Insider support; unreconciled with AR26 tables
30 Jun 2025FY2025 year end: cash A$0.88M; borrowings A$5.33MBalance sheet shifts to debt funding
29 Aug 2025FY2025 Annual Report: revenue A$3.26M; net loss A$4.12MLoss widens 39% [AGG – Simply Wall St]
Sep 2025 quarterRevenue A$0.70MSoft start to FY2026
12 Nov 2025Cleansing notice lodged with ASXRelated to securities issue (option exercise)
27 Nov 2025AGM; Chairman and CEO addresses; options to lenders approvedGovernance and financing
Dec 2025CEO salary raised to A$311,400Remuneration
17–18 Dec 20253M unquoted options issued (A$0.20, expiring Nov 2029)Loan consideration
Dec 2025 quarterRevenue about A$0.38M; cash A$1.44M; purchase-order pipeline above A$0.8MWeakest quarter; orders deferred to 2026
29 Jan 2026Quarterly: Syncromesh at Luna Park Melbourne; Budweiser APAC opening orders; major OEM anti-corrosion ordersCommercial validation
27 Feb 2026H1 FY2026: revenue down 27.6% to A$1.08M; loss attributable A$2.62MWeak half
27 Feb 2026Change of Directors' Interest notices (Stang, Kritzler); change in substantial holding (Bernard Stang)Ownership and financing changes
Mar 2026 quarterRevenue A$0.73M; 53% gross margin; cash A$0.54M; unused facilities A$2.25MLiquidity tight
30 Apr 2026Two new unsecured related-party loan facilities; Omni launch targeted for Q1 FY2027; Mould Stop Paint referencedFunding runway extended
1 May 2026China Hazardous Chemicals Safety Law takes effectRegulatory tailwind cited
Jun 2026 quarterUAE OEM repeat order ~A$308k; customers added in Saudi Arabia, Qatar and the UAECorrosion becoming recurring
Jun 2026 quarterBudweiser expands to six breweries; Yanjing initial orderChina scaling
Jun 2026US consumables launch on Amazon (per Kalkine summary [AGG])New US channel
29 Jul 2026Quarterly: revenue A$1.27M (record); cash receipts A$0.78M; cash A$2.05M; borrowings received A$3.27M in the quarterStrongest quarter; still debt-funded
29 Jul 2026Syncromesh named preferred hardware for a partner's building-software platformOEM channel
28 Aug 2026FY2026 Annual Report and Appendix 4E: revenue A$3.08M (-5.5%); net loss A$5.17M (+25.4%); net liabilities A$9.22MGoing-concern material uncertainty
28 Aug 2026Borrowings of A$12.34M reclassified to current; Directors intend to negotiate an extensionKey financing monitorable
28 Aug 2026AR26 discloses that a 2026 capital raise has been investigatedPotential dilution
Post 30 Jun 2026First US coil-manufacturer corrosion orderUS entry for corrosion range
Sep 2026China's new National Food Safety Standard takes effectRegulatory tailwind cited
Jul–Oct 2026Syncromesh Omni commercial launch windowExecution test

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit (FY2022–FY2026): Revenue rose from AUD 2.7 Mn in FY2022 to AUD 3.1 Mn in FY2026.
Aeris Environmental Ltd — Income Statement: Revenue & Gross Profit (FY2022–FY2026)
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue2.71.933.33.1
Revenue from contracts with customers———33
Gross profit on sales1.20.9—1.41.5

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.